These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32822778)

  • 1. Studying effect of glyceryl palmitostearate amount, manufacturing method and stability on polymorphic transformation and dissolution of rifaximin tablets.
    Dharani S; Barakh Ali SF; Afrooz H; Khan MA; Rahman Z
    Int J Pharm; 2020 Nov; 589():119785. PubMed ID: 32822778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Discriminatory Dissolution Method for Rifaximin Products.
    Dharani S; Barakh Ali SF; Afrooz H; Khan MA; Rahman Z
    J Pharm Sci; 2019 Jun; 108(6):2112-2118. PubMed ID: 30685397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding effect of formulation and manufacturing variables on the critical quality attributes of warfarin sodium product.
    Rahman Z; Korang-Yeboah M; Siddiqui A; Mohammad A; Khan MA
    Int J Pharm; 2015 Nov; 495(1):19-30. PubMed ID: 26319638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
    Bellur Atici E; Karlığa B
    J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations.
    Korang-Yeboah M; Rahman Z; Shah D; Mohammad A; Wu S; Siddiqui A; Khan MA
    Int J Pharm; 2016 Feb; 499(1-2):20-28. PubMed ID: 26688036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the Water Sorption Capacity of Rifaximin Using the Dynamic Vapor Sorption Technique for Optimization of the Choice of Excipients and the Manufacturing Environment of Rifaximin Tablets.
    Ketha NVDP; Bapatu HR; Ummiti K; Subbappa PK; Kolli D
    J AOAC Int; 2023 Nov; 106(6):1464-1470. PubMed ID: 37676832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of processing parameters and controlled environment storage on the disproportionation and dissolution of extended-release capsule of phenytoin sodium.
    Rahman Z; Dharani S; Barakh Ali SF; Afrooz H; Reddy IK; Khan MA
    Int J Pharm; 2018 Oct; 550(1-2):290-299. PubMed ID: 30031866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
    Patel NV; Chotai NP; Patel MP
    Pharmazie; 2008 Apr; 63(4):275-81. PubMed ID: 18468386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical stability and solubility of the thermotropic mesophase of fenoprofen calcium as pure drug and in a tablet formulation.
    Patterson J; Bary A; Rades T
    Int J Pharm; 2002 Oct; 247(1-2):147-57. PubMed ID: 12429493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets.
    Lai F; Pini E; Angioni G; Manca ML; Perricci J; Sinico C; Fadda AM
    Eur J Pharm Biopharm; 2011 Nov; 79(3):552-8. PubMed ID: 21820052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Chitin Source and Polymorphism on Powder Compression and Compaction: Application in Drug Delivery.
    Al-Hmoud L; Abu Fara D; Rashid I; Chowdhry BZ; Badwan AA
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33198143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA.
    Wlodarski K; Tajber L; Sawicki W
    Eur J Pharm Biopharm; 2016 Dec; 109():14-23. PubMed ID: 27658987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
    Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
    Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A One-Step Twin-Screw Melt Granulation with Gelucire 48/16 and Surface Adsorbent to Improve the Solubility of Poorly Soluble Drugs: Effect of Formulation Variables on Dissolution and Stability.
    Sarabu S; Kallakunta VR; Butreddy A; Janga KY; Ajjarapu S; Bandari S; Zhang F; Murthy SN; Repka MA
    AAPS PharmSciTech; 2021 Feb; 22(3):79. PubMed ID: 33606113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking of crystalline-amorphous transition of carvedilol in rotary spun microfibers and their formulation to orodispersible tablets for in vitro dissolution enhancement.
    Szabó P; Sebe I; Stiedl B; Kállai-Szabó B; Zelkó R
    J Pharm Biomed Anal; 2015 Nov; 115():359-67. PubMed ID: 26280924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Itraconazole Liquisolid Compact: Effect of Polyvinylpyrrolidone on the Dissolution Properties.
    Gong W; Wang Y; Sun L; Yang J; Shan L; Yang M; Gao C
    Curr Drug Deliv; 2016; 13(3):452-61. PubMed ID: 26882116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive evaluation of pharmaceutical properties of direct compression tablets containing theophylline anhydrate during storage at high humidity by near-infrared spectroscopy.
    Otsuka Y; Yamamoto M; Tanaka H; Otsuka M
    Biomed Mater Eng; 2015; 25(3):223-36. PubMed ID: 26407109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of wet-granulation process parameters on the dissolution and physical stability of a solid dispersion.
    Kinoshita R; Ohta T; Shiraki K; Higashi K; Moribe K
    Int J Pharm; 2017 May; 524(1-2):304-311. PubMed ID: 28389363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination of polymorphic impurity by X-ray powder diffractometry in an OROS formulation.
    Varasteh M; Deng Z; Hwang H; Kim YJ; Wong GB
    Int J Pharm; 2009 Jan; 366(1-2):74-81. PubMed ID: 18840515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dextrose monohydrate as a non-animal sourced alternative diluent in high shear wet granulation tablet formulations.
    Mitra B; Wolfe C; Wu SJ
    Drug Dev Ind Pharm; 2018 May; 44(5):817-828. PubMed ID: 29300107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.